FDA Investigator Scott N Lim
Scott N Lim has inspections in 7 countries as of 14 Dec 2023. Scott N Lim has collaborated with a combinined 3745 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
49
Last Inspection Date:
14 Dec 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Canada,
India,
Bulgaria,
Korea (Republic of),
United Kingdom of Great Britain and Northern Ireland
Co-Investigator(s):
Alan L Truong,
Alan P Kurtzberg,
Alanna Lmussawwir Bias,
Alex G Kalugin,
Alicia A Borg Borm,
Amir Alavi,
Andersoneric,
Andrea A Branche,
Andrea George, PhD,
Angel K Sandhu,
Angela E Glenn,
Anh M Lac,
Anita Narula, PhD,
Arsen Karapetyan,
Ashar P Parikh,
Atul J Agrawal,
Barbara J Rincon,
Barbara J White,
Barbara J Wilcox, PhD,
Binh T Nguyen,
Bo Chi, PhD,
Calvin B Koerner,
Carl Lee,
Carla J Lundi,
Carole L Jones,
Carolyn A Renshaw,
Carr Sharpe,
Carrie A Hughes,
Caryn M Mcnab,
CDR Ileana Barreto Pettit,
CDR Rochelle B Young, RPh, MSA,
Cecilia H Kieu,
Celena Ngo,
Cheryl A Clausen,
Christopher D Leach,
Christopher M Jenner,
Christopher R Czajka,
Christopher S Keating,
Christopher T Middendorf,
Claudia Mperez Kasmarski,
Clinton J Lott,
Connie P Rezendes,
Daniel J Lahar,
Daniel J Roberts,
David G Eng,
David J Gomes,
Deborah A Greco,
Diana L Ayala,
Dipesh K Shah,
Donald B Mckechnie,
Dr. Mark J Seaton, PhD,
Dr. Ralph M Bernstein, PhD,
Dustin M James,
Dustin P Tran,
Dustin R Abaonza,
Edith M Gonzalez,
Emily Shacter,
Eric L Dong, BS,
Frances Namuswe, PhD,
Gerald Feldman,
Gerald M Feldman, PhD,
Henry K Lau,
Henry X Lau,
Humberto Z Gomez,
Isabel Y Espinosa,
Jacob W Reynolds,
Jai P Singh,
James C Lee, PharmD,
James R Evans,
Jannifer L Degroot,
Jeanne Fringer, PhD,
Jeffrey M Watson,
Jeffrey P Raimondi,
Jennifer Crumb,
Jennifer L Degroot,
Jennifer L Johnson,
Jennifer Swisher, PhD,
Joan T Briones,
Joel Welch, PhD,
John A Gonzalez,
Jose Acruz Gonzalez,
Jose Alopez Rubet,
Joseph Kutze, PhD,
Joseph P Iser, MD,
Joseph R Lambert,
Joshua P Wireman,
Joshua S Hunt,
Juan Rjimenez Garcia,
June P Page,
Kathryn E King,
Keith O Webber, PhD,
Keith Webber, PhD,
Kelley,
Kellia N Hicks,
Kenneth S Boehnen,
Kent A Conforti,
Kevin P Foley,
Kham Phommachanh,
Khoa Nathanv Tran,
Kouros Kangarli,
Kristin M Abaonza,
Lakisha M Williams,
Lam,
Lance M De Souza, MBA,
Lance W Bohm,
Laurie Graham,
Laurie P Norwood,
LCDR Jennifer H Rhyu,
Liming Zhang,
Linan Ha, PhD,
Linda F Murphy,
Linh Tu,
Lisa Shin,
Lucila B Nwatu,
Mabel M Lee,
Maida Henesian (NMI),
Marcus A Goshen,
Marie K Kinkade,
Mariza M Jafary,
Marsha W Major,
Marshalette Edwards,
Marshalette O Edwards,
Mary Ewilkerson Brinsko,
Matthew A Johnson,
Matthew B Casale,
Mei Chiung J Huang,
Michael D Garcia,
Michael R Goga,
Michael Shanks, MS,
Michael T Cyrus,
Michelle Rfrazier Jessen, PhD,
Mihaly S Ligmond,
Mikhail V Ovanesov, PhD,
Milos Dokmanovic, PhD,
Min Shanma Liu,
Muralidhara B Gavini, PhD,
Nabeela J Chaudhry,
Nadeem I Chaudhry,
Nancy E Byerly,
Natalia Pripuzova, PhD,
Nayan J Patel,
Nayan Patel,
Nicholas L Hunt,
Nicholas Obiri, PhD,
Omotunde O Osunsanmi,
Patricia F Hughes, PhD,
Patrick C Klotzbuecher,
Peter E Baker,
Peter Kessler, PhD,
Qing Joanna Zhou, PhD,
Raymond T Oji,
Reba A Gates,
Rebecca Rodriguez,
Rebecca T Davis,
Reyes Candau Chacon, PhD,
Riley C Myers, PhD,
Robert D Tollefsen,
Roger F Zabinski,
Rumany C Penn, PharmD,
Ruth Moore, PhD,
Saied A Asbagh,
Sammie P La,
Sandra S Saniga,
Sangeeta M Khurana, PhD,
Santiago Gallardo Johnson,
Seneca D Toms,
Serge Beaucage,
Sharon K Thoma, PharmD,
Shelby N Turner,
Shelley H Beausoleil,
Sherri J Jackson,
Sherrie M La,
Sidney B Priesmeyer,
Sonia R Peterson,
Sri Ramakrishnaiah Yellela,
State Agency,
Stephanie A Slater, MS,
Stuart W Russell,
Terrence Gee,
Thao T Kwan,
Thea C Grome,
Theresa Kirkham (NMI),
Thomas J Arista,
Thomas W Gordon,
Thuy T Nguyen, LCDR,
Tiara Nbrown Crosen,
Timothy C Grome,
Timothy T Kapsala,
Tomika L Bivens,
Tracy Denison, PhD,
Truong Xuan Nguyen (Andy),
Uttaniti Limchumroon (Tom),
Vaishali J Patel,
Vashti E Bocker,
Victoria L Palmer,
Virgilio F Pacio, CSO,
Viviana Matta,
Walden H Lee,
William A Burkey,
William J Leonard,
William V Millar,
Yi Wang, PhD,
Yumi J Hiramine,
Zachary A Bogorad,
Zachary L Stamm
Scott N Lim's Documents
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more